Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha
Browsing: drug
Travere gains on full FDA approval for kidney drug Filspari Source: Seekingalpha
Psyence Biomedical to acquire drug developer Clairvoyant Source: Seekingalpha
Stifel starts ORIC at purchase, cites prostate cancer drug candidate Source: Seekingalpha
Cigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket Source: Seekingalpha
Eli Lilly bets $409M for AI-focused drug discovery Source: Seekingalpha
Lisata jumps on FDA orphan drug status for liver cancer drug Source: Seekingalpha
Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha
Travere gains on full FDA approval for kidney drug Filspari Source: Seekingalpha
Psyence Biomedical to acquire drug developer Clairvoyant Source: Seekingalpha